Archive - February 2021
Moderna sends South Africa variant-specific vaccine for clinical study
NHS Commercial Framework provides ‘welcome clarity’, says ABPI
Clinical Trial Testing Safety of Abortion Drugs, via the Mail
One month in, how Biden has changed disaster management and the US COVID-19 response
J&J submits one-dose COVID-19 vaccine to WHO for emergency use listing
bluebird bio posts modest Q4 revenue growth as it continues investigation into troubled LentiGlobin
Sanofi, Regeneron’s Libtayo scores first-line NSCLC approval in the US
FDA fast-tracks review of Incyte’s Jakafi for chronic GVHD